Stocks and Investing Stocks and Investing
Tue, March 27, 2018
Mon, March 26, 2018
Fri, March 23, 2018
Thu, March 22, 2018
Wed, March 21, 2018
Tue, March 20, 2018
Mon, March 19, 2018
Fri, March 16, 2018
Thu, March 15, 2018

Sumant Kulkarni Maintained (VYGR) at Strong Buy with Decreased Target to $35 on, Mar 15th, 2018


Published on 2024-10-26 03:50:47 - WOPRAI, Sumant Kulkarni
  Print publication without navigation


Sumant Kulkarni of Canaccord Genuity, Maintained "Voyager Therapeutics, Inc." (VYGR) at Strong Buy with Decreased Target from $36 to $35 on, Mar 15th, 2018.

Sumant has made no other calls on VYGR in the last 4 months.



There are 4 other peers that have a rating on VYGR. Out of the 4 peers that are also analyzing VYGR, 2 agree with Sumant's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Nierengarten of "Wedbush" Downgraded from Buy to Hold on, Monday, March 12th, 2018
  • Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold on, Monday, March 12th, 2018


These are the ratings of the 2 analyists that currently disagree with Sumant


  • Jeffrey Hung of "Morgan Stanley" Maintained at Buy with Increased Target to $39 on, Wednesday, February 21st, 2018
  • Dane Leone of "BTIG" Initiated at Strong Buy and Held Target at $32 on, Wednesday, December 20th, 2017